Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol. (2022)
Attributed to:
Real-world treatment effectiveness in people with type 2 diabetes: Maximising the applicability of clinical trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-066491
PubMed Identifier: 36302574
Publication URI: http://europepmc.org/abstract/MED/36302574
Type: Journal Article/Review
Volume: 12
Parent Publication: BMJ open
Issue: 10
ISSN: 2044-6055